Rachel Pessah-Pollack, M.D., F.A.C.E.

Super excited our ‘Update on Endocrine Disorders During Pregnancy’ is officially published 📘- incredible collab with endocrine gurus @MariaPapaleont1 @nyuendocrine @NYUGSOM_DGIMCI @ElsevierConnect #EndoTwitter #Pregnancy @TheEndoSociety @TheAACE @AmThyroidAssn

Thanks for having me @NYUDocs. Such interesting listener questions! 📞📻#osteoporosis #bone #exercise

Non-English language preference linked to significantly lower #CGM prescription rates in #T2D, even among high-risk insulin users (7.6–7.8% gaps) — independent of clinical factors. Those who could benefit most may be missing out. bit.ly/4nqvnCX @DrPess @JAMANetworkOpen

Choice of #GLP1 matters

Tirzepatide in a target emulation trial demonstrates significantly lower MACE (HR 0.8) and all cause mortality (HR 0.6) compared to dulaglutide in T2DM. 🤯 #ADASciSessions #ADA2025

The oral non-peptide GLP-1 agonist space is quickly filling up #ADA2025 #ADASciScessions

Thanks for featuring me in this article. Beyond crucial we prioritize #bone loss prevention! #Health #osteoporosis @GoHealio

📢“You want these patients to be as mobile as possible,” said @DrPess from @UW. Read more about #osteoporosis in #rheumatoidarthritis @HealioRheum 👇 healio.com/news/rheumatol…

@ENirenberg This is a wild story that anyone interested in or supplementing vitamin D should read — thank you very much for sharing it. @DrNadolsky @DrKarlNadolsky had a nice pod on the topic last summer w @DrPess podcasts.apple.com/us/podcast/doc…

Switching to #tirzepatide was superior to increasing to dulaglutide 4.5mg a week for both A1c and weight loss:  acpjournals.org/doi/10.7326/AN… @AnnalsofIM

In those taking tirzepatide in SURMOUNT-1, of the weight lost approximately 75% was fat mass and 25% was lean mass. This degree of lean mass loss is consistent with other medications. Tirzepatide was not associated with a proportionally greater loss of lean tissue in older adults, who are at higher risk for frailty/sarcopenia.

@mike_natter @nyuendocrine @NYULH_DeptofMed Thank you @mike_natter!

So honored to receive this promotion. Grateful to my incredible mentors who helped me on this journey. @nyuendocrine @NYULH_DeptofMed

Congratulations!

January is #ThyroidAwarenessMonth! 🦋 Dr. Rachel Pessah-Pollack, MD, FACE, shares why thyroid health matters year-round. Let’s raise awareness and support those living with thyroid conditions! Head over to our LinkedIn to see the full quote from @DrPess: shorturl.at/TkSJg

There is no shame in taking a medicine for your weight just like there is no shame in taking a medicine for your high blood pressure or depression.

Amazing talk! Loved hearing about all the thyroid history that got us where we are today. #2024ATA @AngelaLeung9

Favorite part of #2024ATA - catching up with friends across the 🌎#2024ATA #thyroid @AngelaLeung9 @MariaPapaleont1

Would be a good read. An area of interest.

Reserving your incredible artistic skills for the next cover! Thanks for the support @mike_natter

@draarongrotas Agreed!

Brilliant analogy @DrPess